The findings presented by Fu et al. indicated that exosomal TRIM3 could potentially serve as a biomarker for the diagnosis of gastric cancer and the delivery of TRIM3 via exosomes may offered a novel approach for the treatment of gastric cancer (Fu et al., 2018). Here, TRIM3 is linked to gastric cancer.